Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Coloplast Norge AS
AS
Active
Org 931925822
Ryenstubben 10, 0679
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1981 · 44 years old
48 employees
www.coloplast.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Coloplast Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
609M
457M
304M
152M
0M
2021: 395M
395M
2021
2022: 415M (+5% vs 2021)
415M
+5%
2022
2023: 433M (+4% vs 2022)
433M
+4%
2023
2024: 450M (+4% vs 2023)
450M
+4%
2024
2025: 489M (+9% vs 2024)
489M
+9%
2025
EBITDA
NOK millions
52M
39M
26M
13M
0M
2021: 31M
31M
2021
2022: 35M (+13% vs 2021)
35M
+13%
2022
2023: 41M (+17% vs 2022)
41M
+17%
2023
2024: 34M (-17% vs 2023)
34M
-17%
2024
2025: 42M (+24% vs 2024)
42M
+24%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
488 689
449 647
433 398
415 099
395 380
Staff expenses
−52 679
−44 032
−38 280
−36 692
−33 029
EBITDA
42 476
33 885
40 500
35 167
30 892
Depreciation & amort.
−924
−758
−471
−323
−313
EBIT
41 552
33 126
40 029
34 845
30 579
Net financials
2 653
1 950
946
−397
1 377
Profit before tax
44 205
35 076
40 975
34 448
31 956
Tax
9 864
7 836
9 134
7 734
7 132
Net profit
34 341
27 240
31 841
26 714
24 825
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
140 637
95 767
89 039
91 832
108 242
Equity
21 585
13 086
12 105
6 256
14 242
Long-term debt
0
0
0
0
0
Short-term debt
119 052
82 681
76 934
85 576
94 000
Total debt
119 052
82 681
76 934
85 576
94 000
Financial ratios
5-year trend
EBITDA margin
8,7 %
This company
15,8 %
Market median
This company
Market median
45% below market
2021
2025
Equity ratio
15,3 %
This company
38,2 %
Market median
This company
Market median
60% below market
2021
2025
Return on equity
159,1 %
This company
18,4 %
Market median
This company
Market median
765% above market
2021
2025
Net profit margin
7,0 %
This company
8,1 %
Market median
This company
Market median
14% below market
2021
2025
Asset turnover
3,47×
This company
1,12×
Market median
This company
Market median
210% above market
2021
2025
Debt / equity
5,52×
This company
0,62×
Market median
This company
Market median
790% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-10-01 – 2021-09-30
View
PDF
More on Coloplast Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
